← Evidence map

ArticleTherapeutic advances in medical oncology2024

Pre-treatment pan-immune-inflammation value as a prognostic marker of pazopanib in soft tissue sarcoma.

Cheng-Han Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39479475